P04836
Gene name |
CPE |
Protein name |
Carboxypeptidase E |
Names |
CPE, Carboxypeptidase H, CPH, Enkephalin convertase, Prohormone-processing carboxypeptidase |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:280753 |
EC number |
3.4.17.10: Metallocarboxypeptidases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P04836
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P04836-F1 | Predicted | AlphaFoldDB |
30 variants for P04836
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs456742286 | 25 | A>P | No | EVA | |
| rs470515301 | 26 | E>V | No | EVA | |
| rs432802035 | 35 | A>G | No | EVA | |
| rs1116425083 | 58 | L>P | No | EVA | |
| rs452638483 | 100 | E>* | No | EVA | |
| rs473131322 | 148 | T>P | No | EVA | |
| rs455392821 | 160 | G>A | No | EVA | |
| rs441760506 | 160 | G>R | No | EVA | |
| rs475208122 | 161 | F>L | No | EVA | |
| rs443795754 | 165 | A>P | No | EVA | |
| rs458125194 | 170 | E>D | No | EVA | |
| 255 | Y>H | No | |||
| rs463982368 | 278 | Q>H | No | EVA | |
| rs439557610 | 279 | S>I | No | EVA | |
| rs471010720 | 279 | S>R | No | EVA | |
| rs434206233 | 304 | D>E | No | EVA | |
| rs434699463 | 368 | I>L | No | EVA | |
| rs435183101 | 373 | R>Q | No | EVA | |
| rs1114781374 | 380 | R>Q | No | EVA | |
| rs444465262 | 406 | D>Y | No | EVA | |
| rs210567645 | 414 | V>I | No | EVA | |
| rs716791655 | 425 | P>L | No | EVA | |
| rs475569712 | 446 | F>I | No | EVA | |
| rs444347458 | 453 | E>K | No | EVA | |
| rs451574662 | 453 | E>V | No | EVA | |
| rs471422638 | 456 | E>D | No | EVA | |
| rs439564363 | 458 | E>D | No | EVA | |
| rs439969348 | 460 | E>A | No | EVA | |
| rs460239686 | 466 | W>C | No | EVA | |
| rs442450617 | 476 | F>Q | No | EVA |
No associated diseases with P04836
Functions
| Description | ||
|---|---|---|
| EC Number | 3.4.17.10 | Metallocarboxypeptidases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| Golgi apparatus | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. |
| secretory granule membrane | The lipid bilayer surrounding a secretory granule. |
| transport vesicle membrane | The lipid bilayer surrounding a transport vesicle. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| cell adhesion molecule binding | Binding to a cell adhesion molecule. |
| metallocarboxypeptidase activity | Catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. |
| neurexin family protein binding | Binding to a neurexin, a synaptic cell surface protein related to latrotoxin receptor, laminin and agrin. Neurexins act as cell recognition molecules at nerve terminals. |
| zinc ion binding | Binding to a zinc ion (Zn). |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| cardiac left ventricle morphogenesis | The process in which the left cardiac ventricle is generated and organized. |
| insulin processing | The formation of mature insulin by proteolysis of the precursor preproinsulin. The signal sequence is first cleaved from preproinsulin to form proinsulin; proinsulin is then cleaved to release the C peptide, leaving the A and B chains of mature insulin linked by disulfide bridges. |
| peptide hormone secretion | The regulated release of a peptide hormone from a cell. |
| peptide metabolic process | The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. |
| protein localization to membrane | A process in which a protein is transported to, or maintained in, a specific location in a membrane. |
| protein localization to secretory granule | A process in which a protein is transported to, or maintained in, a location within a secretory granule. |
| protein processing | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. |
| Wnt signaling pathway | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
16 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q2KJ83 | CPN1 | Carboxypeptidase N catalytic chain | Bos taurus (Bovine) | PR |
| Q8QGP3 | CPZ | Carboxypeptidase Z | Gallus gallus (Chicken) | PR |
| Q8IUX7 | AEBP1 | Adipocyte enhancer-binding protein 1 | Homo sapiens (Human) | PR |
| O75976 | CPD | Carboxypeptidase D | Homo sapiens (Human) | PR |
| Q8N436 | CPXM2 | Inactive carboxypeptidase-like protein X2 | Homo sapiens (Human) | PR |
| Q66K79 | CPZ | Carboxypeptidase Z | Homo sapiens (Human) | PR |
| Q96SM3 | CPXM1 | Probable carboxypeptidase X1 | Homo sapiens (Human) | PR |
| P14384 | CPM | Carboxypeptidase M | Homo sapiens (Human) | PR |
| Q80V42 | Cpm | Carboxypeptidase M | Mus musculus (Mouse) | PR |
| O89001 | Cpd | Carboxypeptidase D | Mus musculus (Mouse) | PR |
| Q9JJN5 | Cpn1 | Carboxypeptidase N catalytic chain | Mus musculus (Mouse) | PR |
| Q9Z100 | Cpxm1 | Probable carboxypeptidase X1 | Mus musculus (Mouse) | PR |
| Q9D2L5 | Cpxm2 | Inactive carboxypeptidase-like protein X2 | Mus musculus (Mouse) | PR |
| Q640N1 | Aebp1 | Adipocyte enhancer-binding protein 1 | Mus musculus (Mouse) | PR |
| Q9EQV8 | Cpn1 | Carboxypeptidase N catalytic chain | Rattus norvegicus (Rat) | PR |
| A2RUV9 | Aebp1 | Adipocyte enhancer-binding protein 1 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MARRGGCALL | VLCGSLAACA | WLLGAEARGP | GGPVAGARRR | RRPQEDGISF | EYHRYPELRE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ALVSVWLQCA | AVSRIYTVGR | SFEGRELLVL | ELSDNPGVHE | PGEPEFKYIG | NMHGNEAVGR |
| 130 | 140 | 150 | 160 | 170 | 180 |
| ELLIFLAQYL | CNEYQKGNET | IVQLIHNTRI | HIMPSLNPDG | FEKAASQLGE | LKDWFVGRSN |
| 190 | 200 | 210 | 220 | 230 | 240 |
| AQGIDLNRNF | PDLDRIVYIN | EKEGGPNNHL | LKNLKKIVDQ | NTKLAPETKA | VIHWIMDIPF |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VLSANLHGGD | LVANYPYDET | RSGSAHEYSS | CPDDDIFQSL | ARAYSSFNPP | MSDPDRPPCR |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KNDDDSSFVE | GTTNGAAWYS | VPGGMQDFNY | LSSNCFEITV | ELSCEKFPPE | ETLKNYWEDN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KNSLISYIQQ | IHRGVKGFVR | DLQGNPIANA | TLSVEGIDHD | VTSAKDGDYW | RLLVPGNYKL |
| 430 | 440 | 450 | 460 | 470 | |
| TASAPGYLAI | AKKVAVPYSP | AVRVDFELES | FSERKEEEKE | ELMEWWKMMS | ETLNF |